Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders
Author:
Funder
National Institute for Health Research
King’s College London
South London and Maudsley NHS Foundation Trust
Publisher
Elsevier BV
Subject
General Medicine
Reference68 articles.
1. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study;Abbasi;J. Affect. Disord.,2012
2. Minocycline produced antidepressant-like effects on the learned helplessness rats with alterations in levels of monoamine in the amygdala and no changes in BDNF levels in the hippocampus at baseline;Arakawa;Pharmacol. Biochem. Behav.,2012
3. Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: back to the future;Asadi;J Glob Antimicrob Resist,2020
4. Minocycline alleviates depression-like symptoms by rescuing decrease in neurogenesis in dorsal hippocampus via blocking microglia activation/phagocytosis;Bassett;Brain Behav. Immun.,2021
5. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms;Block;Nat. Rev. Neurosci.,2007
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New and emerging treatments for major depressive disorder;BMJ;2024-07-08
2. Formation mechanisms of mental disorders in people living with HIV;Medicine Today and Tomorrow;2024-04-01
3. Advancements Exploring Major Depressive Disorder: Insights on Oxidative Stress, Serotonin Metabolism, BDNF, HPA Axis Dysfunction, and Pharmacotherapy Advances;International Journal of Translational Medicine;2024-03-05
4. Mood and microbes: a comprehensive review of intestinal microbiota’s impact on depression;Frontiers in Psychiatry;2024-02-09
5. Exploring Clinical Subgroups of Participants with Major Depressive Disorder that may Benefit from Adjunctive Minocycline Treatment;CLIN PSYCHOPHARM NEU;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3